B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

Yan Xiao-Jie; Palacios Florencia; Li Wentian; Yancopoulos Sophia; Calissano Carlo; Barrientos Jacqueline C.; Allen Steven L.; Kolitz Jonathan E.; Rai Kanti; Chiorazzi Nicholas

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

【24h】

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

机译：CLL克隆增殖部分的B细胞表现出活化的B细胞和髓样细胞特征，提示增强的抗原呈递，整联蛋白反应性和IL-4接受性：CLL治疗的其他目标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2016年第22期|共4页
作者
Yan Xiao-Jie; Palacios Florencia; Li Wentian; Yancopoulos Sophia; Calissano Carlo; Barrientos Jacqueline C.; Allen Steven L.; Kolitz Jonathan E.; Rai Kanti; Chiorazzi Nicholas;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy [J] . Yan Xiao-Jie, Palacios Florencia, Li Wentian, Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：CLL克隆增殖部分的B细胞表现出活化的B细胞和髓样细胞特征，提示增强的抗原呈递，整联蛋白反应性和IL-4接受性：CLL治疗的其他目标
2. Clonally-Related CD5+CLL/SLL and CD10+high grade B-cell lymphoma suggests common neoplastic progenitor with branched disease evolution, with therapeutic implications [J] . Leukemia and lymphoma . 2020,第1a2期

机译：克隆相关的CD5 + CLL / SLL和CD10 +高级B细胞淋巴瘤表明常见的肿瘤祖细胞具有分支疾病演化，具有治疗意义
3. Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation [J] . Johnston Harvey E., Carter Matthew J., Larrayoz Marta, Molecular & cellular proteomics: MCP . 2018,第4期

机译：CLL与健康B细胞的蛋白质组学分析鉴定了推定的治疗目标和亚型染色体组织的亚型签名
4. Correction: CLL Cells Respond to B-Cell Receptor Stimulation with a MicroRNA/mRNA Signature Associated with MYC Activation and Cell Cycle Progression [O] . Valerie Pede, Ans Rombout, Jolien Vermeire, -1

机译：校正：CLL细胞响应与MYC激活和细胞周期进程相关的MicroRNA / mRNA签名对B细胞受体的刺激。
5. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy [O] . M Hoogendoorn, J Olde Wolbers, W M Smit, 2004

机译：生成B细胞慢性淋巴细胞白血病（B-CLL） - 使用改性B-CLL细胞作为刺激器的HLA类I匹配供体的反应性T细胞系和克隆：对采用免疫疗法的影响

B Cells of the Proliferative Fraction of CLL Clones Exhibit Activated B-Cell and Myeloid-Cell Signatures Suggesting Enhanced Antigen-Presentation, Integrin Responsiveness, and IL-4 Receptiveness: Additional Targets for CLL Therapy

著录项

相似文献

相关主题

期刊订阅